Ajanta Pharma Limited (AJANTPHARM) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹3,345.5 (+0.22% day change)
Key ratios
- P/E ratio
- 39.58
- P/B ratio
- 7.74
- ROE (%)
- 23.33
- ROCE (%)
- 27.95
- Debt/Equity
- 0.06
- Dividend yield (%)
- 1
- Market cap (₹ Cr)
- 41,805.03
Forensic checks
Piotroski F-Score: 3/9 · Altman Z-Score: 12.41 · Beneish M-Score: -1.66
InvestSights quality score
69.5/100 — Above Average (descriptive data-driven composite; not a recommendation)
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.